US equities
|
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Quince Therapeutics, Inc. - Common Stock
(NQ:
QNCX
)
31.73
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Quince Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Stocks That Hit 52-Week Lows On Tuesday
↗
December 20, 2022
On Tuesday, 298 companies achieved new lows for the year.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
December 08, 2022
During Thursday's trading, 138 companies set new 52-week lows.
Via
Benzinga
Quince Therapeutics Presents Preclinical Data at MHSRS 2022 Demonstrating Preclinical Efficacy of Bone-targeting Platform for Traumatic Bone Injury
September 16, 2022
From
Quince Therapeutics, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
↗
November 04, 2022
Friday's session saw 236 companies set new 52-week lows.
Via
Benzinga
Quince Therapeutics Presents Preclinical Data at ASBMR 2022 Demonstrating Application of Bone-targeting Platform for Spinal Fusion and Bone Cancer Indications
September 12, 2022
From
Quince Therapeutics, Inc.
Via
Business Wire
Quince Therapeutics Presents Preclinical Data at OI 2022 Demonstrating Potential of a Targeted Anabolic for Accelerated Bone Healing of Osteogenesis Imperfecta Fractures
August 30, 2022
From
Quince Therapeutics, Inc.
Via
Business Wire
Quince Therapeutics to Present at Upcoming Scientific Meetings
August 25, 2022
From
Quince Therapeutics, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
↗
August 30, 2022
On Tuesday, 250 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
August 25, 2022
On Thursday, 63 companies set new 52-week lows.
Via
Benzinga
Quince Therapeutics to Present at Canaccord Genuity 42nd Annual Growth Conference on August 11, 2022
August 04, 2022
From
Quince Therapeutics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
